查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1621340

敗血症診斷市場：按測試類型、技術、產品、方法、病原體、最終用戶分類 - 全球預測 2025-2030

Sepsis Diagnostic Market by Testing Type (Laboratory Testing, PoC Testing), Technology (Flow Cytometry, Immunoassays, Microbiology), Product, Method, Pathogen, End-user - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年膿毒症診斷市場價值為5.5686億美元，預計到2024年將達到6.118億美元，複合年成長率為9.98%，到2030年將達到10.8417億美元。

敗血症診斷在醫療保健中發揮重要作用，可以快速識別和管理敗血症，從而降低死亡率並改善患者預後。這種需求源自於敗血症危及生命的性質，需要快速、準確的診斷以啟動及時治療。應用主要包括醫院、診斷實驗室和診所，其中分子診斷、免疫測量和微陣列等測試用於檢測膿毒症的病原體和生物標記。最終用途部分包括醫療保健提供者、綜合護理服務網路、研究設施等。敗血症發病率的上升、診斷技術的進步以及醫療保健專業人員對早期診斷的認知不斷提高推動了市場成長。基於人工智慧的診斷工具和即時檢測設備等創新提供了巨大的成長機會。此外，政府遏制敗血症的努力以及對醫療基礎設施的投資，尤其是在新興國家，也增強了市場前景。抓住機會的建議包括促進技術整合合作以及透過研發擴大精準診斷能力。然而，它面臨著先進診斷系統成本高、缺乏標準化通訊協定以及敗血症的複雜性等挑戰，使診斷變得複雜。此外，監管挑戰和報銷問題限制了採用率。為了克服這些挑戰，專注於負擔得起且易於使用的診斷解決方案並透過教育提高意識可以產生重大影響。診斷中的生物資訊學和機器學習作為具有提高診斷準確性和效率的潛力的研究途徑而受到關注。總體而言，敗血症診斷市場的特點是動態的技術發展和關鍵的需求，具有充足的創新主導成長空間，同時需要解決成本和複雜性障礙以實現更廣泛的可及性。

主要市場統計
基準年[2023] 55686萬美元
預計年份 [2024] 6.118 億美元
預測年份 [2030] 10.8417 億美元
複合年成長率（%） 9.98%

市場動態：快速發展的敗血症診斷市場的關鍵市場洞察

敗血症診斷市場正因供需的動態交互作用而轉變。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助消費行為及其對製造業的影響。

  • 市場促進因素
    • 敗血症的發生率和盛行率增加
    • 醫院傳播感染疾病增加
    • 先進診斷解決方案技術的開發
  • 市場限制因素
    • 資本集中自動化診斷服務和報銷不佳
  • 市場機會
    • 全球快速診斷的不斷發展
    • 開發用於膿毒症診斷的新生物標記
  • 市場挑戰
    • 缺乏程序意識和標準通訊協定

波特五力：引領敗血症診斷市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解敗血症診斷市場的外部影響

外部宏觀環境因素在塑造敗血症診斷市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解敗血症診斷市場的競爭格局

對膿毒症診斷市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣敗血症診斷市場供應商的績效評估

FPNV 定位矩陣是評估敗血症診斷市場供應商的關鍵工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了膿毒症診斷市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，膿毒症診斷市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開發：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、未開發地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 敗血症的發生率和盛行率增加
      • 醫院感染增加
      • 技術開發先進診斷解決方案
    • 抑制因素
      • 資本密集型自動化診斷服務和報銷短缺
    • 機會
      • 快速診斷方法在全球迅速發展
      • 開發用於膿毒症診斷的新生物標記
    • 任務
      • 缺乏程序意識和標準通訊協定
  • 市場區隔分析
    • 測試類型：增加使用 PoC 測試解決方案進行敗血症診斷
    • 最終用戶：先進膿毒症診斷解決方案在病理學和參考實驗室中的新用途
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章膿毒症診斷市場（依測試類型）

  • 臨床檢查
  • 概念驗證測試

第7章膿毒症診斷市場：依技術分類

  • 流式細胞技術
  • 免疫檢測
  • 微生物學
  • 分子診斷

第 8 章膿毒症診斷市場：依產品

  • 檢測套件和試劑
  • 血培養基
  • 裝置
  • 軟體

第9章膿毒症診斷市場：依方法分類

  • 自動診斷
  • 常規診斷

第10章膿毒症診斷市場（按病原體）

  • 細菌性敗血症
    • 革蘭氏陰性菌
    • 革蘭氏陽性菌
  • 黴菌性敗血症

第11章膿毒症診斷市場：依最終用戶分類

  • 醫院
  • 病理學和參考實驗室
  • 研究實驗室和學術機構

第12章北美與南美膿毒症診斷市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第13章亞太地區敗血症診斷市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第14章歐洲、中東和非洲敗血症診斷市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第15章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • Prenosis 宣布 FDA 批准的人工智慧工具
    • Presymptom Health 創新人工智慧驅動的敗血症早期檢測獲得 150 萬英鎊資金
    • Cytovale 透過 C 輪資金籌措獲得 8,400 萬美元的策略推進資金
  • 戰略分析和建議

公司名單

  • Abbott Laboratories
  • Alifax Srl
  • Beckman Coulter, Inc.
  • Becton, Dickinson and Company
  • bioMerieux SA
  • Boditech Med Inc.
  • Bruker Corporation
  • CytoSorbents Corporation
  • DiaSorin SpA
  • EKF Diagnostics
  • F. Hoffmann-La Roche AG
  • Immunexpress Inc.
  • Koninklijke Philips NV
  • McKesson Corporation
  • Merck KGaA
  • Molzym GmbH & Co. KG
  • Nanomix Inc.
  • Oracle Corporation
  • QIAGEN NV
  • Response Biomedical Corporation
  • Seegene Inc.
  • Siemens Healthineers
  • T2 Biosystems
  • Thermo Fisher Scientific, Inc.
  • Wolters Kluwer NV
Product Code: MRR-A339DAEFABA1

The Sepsis Diagnostic Market was valued at USD 556.86 million in 2023, expected to reach USD 611.80 million in 2024, and is projected to grow at a CAGR of 9.98%, to USD 1,084.17 million by 2030.

Sepsis diagnostics play a critical role in healthcare, providing rapid identification and management of sepsis to reduce mortality rates and improve patient outcomes. The necessity arises from sepsis's life-threatening nature, requiring swift and accurate diagnosis to initiate timely treatment. Applications primarily include hospitals, diagnostic laboratories, and clinics, where tests like molecular diagnostics, immunoassays, and microarrays are utilized to detect sepsis pathogens and biomarkers. End-use segments encompass healthcare providers, integrated delivery networks, and research facilities. Market growth is driven by the rising incidence of sepsis, advances in diagnostic technology, and increased awareness among healthcare professionals about early diagnosis. Innovations such as AI-based diagnostic tools and point-of-care testing devices present substantial opportunities for growth. Furthermore, government initiatives to curb sepsis and investments in healthcare infrastructure, especially in emerging economies, also bolster market prospects. Recommendations to seize opportunities include fostering collaborations for technology integration and expanding capabilities in precision diagnostics through R&D. However, market growth faces challenges such as the high cost of advanced diagnostic systems, lack of standardized protocols, and the complexity of sepsis as a condition, which complicates diagnosis. Additionally, regulatory challenges and reimbursement issues limit adoption rates. To navigate these challenges, focusing on affordable, accessible diagnostic solutions and enhancing awareness through education can yield significant dividends. Bioinformatics and machine learning in diagnostics stand out as potential research avenues, offering prospects for improved diagnostic accuracy and efficiency. Overall, the sepsis diagnostic market is characterized by dynamic technological evolution and a critical demand, presenting ample scope for innovation-driven growth while necessitating addressing cost and complexity barriers for broader accessibility.

KEY MARKET STATISTICS
Base Year [2023] USD 556.86 million
Estimated Year [2024] USD 611.80 million
Forecast Year [2030] USD 1,084.17 million
CAGR (%) 9.98%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Sepsis Diagnostic Market

The Sepsis Diagnostic Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing Incidence and Prevalence of Sepsis
    • Growing Occurrence of Hospital Derived Infections
    • Development of Technology Advanced Diagnostic Solutions
  • Market Restraints
    • Capital Intensive Automated Diagnostic Services and Dearth of Reimbursement Situations
  • Market Opportunities
    • Emerging Development of Rapid Diagnostics Globally
    • Development of Novel Biomarkers for Sepsis Diagnostics
  • Market Challenges
    • Lack of Awareness and Standard Protocols for the Procedure

Porter's Five Forces: A Strategic Tool for Navigating the Sepsis Diagnostic Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Sepsis Diagnostic Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Sepsis Diagnostic Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Sepsis Diagnostic Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Sepsis Diagnostic Market

A detailed market share analysis in the Sepsis Diagnostic Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Sepsis Diagnostic Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Sepsis Diagnostic Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Sepsis Diagnostic Market

A strategic analysis of the Sepsis Diagnostic Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Sepsis Diagnostic Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Alifax S.r.l., Beckman Coulter, Inc., Becton, Dickinson and Company, bioMerieux SA, Boditech Med Inc., Bruker Corporation, CytoSorbents Corporation, DiaSorin S.p.A., EKF Diagnostics, F. Hoffmann-La Roche AG, Immunexpress Inc., Koninklijke Philips N.V., McKesson Corporation, Merck KGaA, Molzym GmbH & Co. KG, Nanomix Inc., Oracle Corporation, QIAGEN N.V., Response Biomedical Corporation, Seegene Inc., Siemens Healthineers, T2 Biosystems, Thermo Fisher Scientific, Inc., and Wolters Kluwer N.V..

Market Segmentation & Coverage

This research report categorizes the Sepsis Diagnostic Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Testing Type, market is studied across Laboratory Testing and PoC Testing.
  • Based on Technology, market is studied across Flow Cytometry, Immunoassays, Microbiology, and Molecular Diagnostics.
  • Based on Product, market is studied across Assay Kits and Reagents, Blood Culture Media, Instruments, and Software.
  • Based on Method, market is studied across Automated Diagnostics and Conventional Diagnostics.
  • Based on Pathogen, market is studied across Bacterial Sepsis and Fungal Sepsis. The Bacterial Sepsis is further studied across Gram-Negative Bacteria and Gram-Positive Bacteria.
  • Based on End-user, market is studied across Hospitals, Pathology & Reference Laboratories, and Research Laboratories & Academic Institutes.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing Incidence and Prevalence of Sepsis
      • 5.1.1.2. Growing Occurrence of Hospital Derived Infections
      • 5.1.1.3. Development of Technology Advanced Diagnostic Solutions
    • 5.1.2. Restraints
      • 5.1.2.1. Capital Intensive Automated Diagnostic Services and Dearth of Reimbursement Situations
    • 5.1.3. Opportunities
      • 5.1.3.1. Emerging Development of Rapid Diagnostics Globally
      • 5.1.3.2. Development of Novel Biomarkers for Sepsis Diagnostics
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of Awareness and Standard Protocols for the Procedure
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Testing Type: Increasing usage of PoC testing solutions for sepsis diagnostics
    • 5.2.2. End-user: Emerging use of advanced sepsis diagnostics solutions in pathology and reference laboratories
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Sepsis Diagnostic Market, by Testing Type

  • 6.1. Introduction
  • 6.2. Laboratory Testing
  • 6.3. PoC Testing

7. Sepsis Diagnostic Market, by Technology

  • 7.1. Introduction
  • 7.2. Flow Cytometry
  • 7.3. Immunoassays
  • 7.4. Microbiology
  • 7.5. Molecular Diagnostics

8. Sepsis Diagnostic Market, by Product

  • 8.1. Introduction
  • 8.2. Assay Kits and Reagents
  • 8.3. Blood Culture Media
  • 8.4. Instruments
  • 8.5. Software

9. Sepsis Diagnostic Market, by Method

  • 9.1. Introduction
  • 9.2. Automated Diagnostics
  • 9.3. Conventional Diagnostics

10. Sepsis Diagnostic Market, by Pathogen

  • 10.1. Introduction
  • 10.2. Bacterial Sepsis
    • 10.2.1. Gram-Negative Bacteria
    • 10.2.2. Gram-Positive Bacteria
  • 10.3. Fungal Sepsis

11. Sepsis Diagnostic Market, by End-user

  • 11.1. Introduction
  • 11.2. Hospitals
  • 11.3. Pathology & Reference Laboratories
  • 11.4. Research Laboratories & Academic Institutes

12. Americas Sepsis Diagnostic Market

  • 12.1. Introduction
  • 12.2. Argentina
  • 12.3. Brazil
  • 12.4. Canada
  • 12.5. Mexico
  • 12.6. United States

13. Asia-Pacific Sepsis Diagnostic Market

  • 13.1. Introduction
  • 13.2. Australia
  • 13.3. China
  • 13.4. India
  • 13.5. Indonesia
  • 13.6. Japan
  • 13.7. Malaysia
  • 13.8. Philippines
  • 13.9. Singapore
  • 13.10. South Korea
  • 13.11. Taiwan
  • 13.12. Thailand
  • 13.13. Vietnam

14. Europe, Middle East & Africa Sepsis Diagnostic Market

  • 14.1. Introduction
  • 14.2. Denmark
  • 14.3. Egypt
  • 14.4. Finland
  • 14.5. France
  • 14.6. Germany
  • 14.7. Israel
  • 14.8. Italy
  • 14.9. Netherlands
  • 14.10. Nigeria
  • 14.11. Norway
  • 14.12. Poland
  • 14.13. Qatar
  • 14.14. Russia
  • 14.15. Saudi Arabia
  • 14.16. South Africa
  • 14.17. Spain
  • 14.18. Sweden
  • 14.19. Switzerland
  • 14.20. Turkey
  • 14.21. United Arab Emirates
  • 14.22. United Kingdom

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2023
  • 15.2. FPNV Positioning Matrix, 2023
  • 15.3. Competitive Scenario Analysis
    • 15.3.1. Unveiling of FDA-Authorized AI Tool by Prenosis, Inc.
    • 15.3.2. Innovative AI-Powered Early Detection of Sepsis by Presymptom Health Secures GBP 1.5 Million in Funding
    • 15.3.3. Cytovale's Strategic Advancement with USD 84 Million Series C Funding
  • 15.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Alifax S.r.l.
  • 3. Beckman Coulter, Inc.
  • 4. Becton, Dickinson and Company
  • 5. bioMerieux SA
  • 6. Boditech Med Inc.
  • 7. Bruker Corporation
  • 8. CytoSorbents Corporation
  • 9. DiaSorin S.p.A.
  • 10. EKF Diagnostics
  • 11. F. Hoffmann-La Roche AG
  • 12. Immunexpress Inc.
  • 13. Koninklijke Philips N.V.
  • 14. McKesson Corporation
  • 15. Merck KGaA
  • 16. Molzym GmbH & Co. KG
  • 17. Nanomix Inc.
  • 18. Oracle Corporation
  • 19. QIAGEN N.V.
  • 20. Response Biomedical Corporation
  • 21. Seegene Inc.
  • 22. Siemens Healthineers
  • 23. T2 Biosystems
  • 24. Thermo Fisher Scientific, Inc.
  • 25. Wolters Kluwer N.V.

LIST OF FIGURES

  • FIGURE 1. SEPSIS DIAGNOSTIC MARKET RESEARCH PROCESS
  • FIGURE 2. SEPSIS DIAGNOSTIC MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 17. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. AMERICAS SEPSIS DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. AMERICAS SEPSIS DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. UNITED STATES SEPSIS DIAGNOSTIC MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 21. UNITED STATES SEPSIS DIAGNOSTIC MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC SEPSIS DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. ASIA-PACIFIC SEPSIS DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 25. EUROPE, MIDDLE EAST & AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 26. SEPSIS DIAGNOSTIC MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 27. SEPSIS DIAGNOSTIC MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. SEPSIS DIAGNOSTIC MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. SEPSIS DIAGNOSTIC MARKET DYNAMICS
  • TABLE 7. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY LABORATORY TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY POC TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY IMMUNOASSAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY MICROBIOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY ASSAY KITS AND REAGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY BLOOD CULTURE MEDIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY AUTOMATED DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY CONVENTIONAL DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY GRAM-NEGATIVE BACTERIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY GRAM-POSITIVE BACTERIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY FUNGAL SEPSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOLOGY & REFERENCE LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY RESEARCH LABORATORIES & ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS SEPSIS DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. ARGENTINA SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 43. ARGENTINA SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 44. ARGENTINA SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 45. ARGENTINA SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2030 (USD MILLION)
  • TABLE 46. ARGENTINA SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2018-2030 (USD MILLION)
  • TABLE 47. ARGENTINA SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 48. BRAZIL SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. BRAZIL SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 50. BRAZIL SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 51. BRAZIL SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 52. BRAZIL SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2030 (USD MILLION)
  • TABLE 53. BRAZIL SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2018-2030 (USD MILLION)
  • TABLE 54. BRAZIL SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 55. CANADA SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. CANADA SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 57. CANADA SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 58. CANADA SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 59. CANADA SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2030 (USD MILLION)
  • TABLE 60. CANADA SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2018-2030 (USD MILLION)
  • TABLE 61. CANADA SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. MEXICO SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. MEXICO SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 64. MEXICO SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 65. MEXICO SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 66. MEXICO SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2030 (USD MILLION)
  • TABLE 67. MEXICO SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2018-2030 (USD MILLION)
  • TABLE 68. MEXICO SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 69. UNITED STATES SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. UNITED STATES SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 71. UNITED STATES SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 72. UNITED STATES SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 73. UNITED STATES SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2030 (USD MILLION)
  • TABLE 74. UNITED STATES SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2018-2030 (USD MILLION)
  • TABLE 75. UNITED STATES SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. UNITED STATES SEPSIS DIAGNOSTIC MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 77. ASIA-PACIFIC SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. ASIA-PACIFIC SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 79. ASIA-PACIFIC SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 80. ASIA-PACIFIC SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 81. ASIA-PACIFIC SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2030 (USD MILLION)
  • TABLE 82. ASIA-PACIFIC SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2018-2030 (USD MILLION)
  • TABLE 83. ASIA-PACIFIC SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. ASIA-PACIFIC SEPSIS DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 85. AUSTRALIA SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. AUSTRALIA SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 87. AUSTRALIA SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 88. AUSTRALIA SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 89. AUSTRALIA SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2030 (USD MILLION)
  • TABLE 90. AUSTRALIA SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2018-2030 (USD MILLION)
  • TABLE 91. AUSTRALIA SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. CHINA SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. CHINA SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 94. CHINA SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 95. CHINA SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 96. CHINA SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2030 (USD MILLION)
  • TABLE 97. CHINA SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2018-2030 (USD MILLION)
  • TABLE 98. CHINA SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. INDIA SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. INDIA SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 101. INDIA SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 102. INDIA SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 103. INDIA SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2030 (USD MILLION)
  • TABLE 104. INDIA SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2018-2030 (USD MILLION)
  • TABLE 105. INDIA SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 106. INDONESIA SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. INDONESIA SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 108. INDONESIA SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 109. INDONESIA SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 110. INDONESIA SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2030 (USD MILLION)
  • TABLE 111. INDONESIA SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2018-2030 (USD MILLION)
  • TABLE 112. INDONESIA SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 113. JAPAN SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. JAPAN SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 115. JAPAN SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 116. JAPAN SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 117. JAPAN SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2030 (USD MILLION)
  • TABLE 118. JAPAN SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2018-2030 (USD MILLION)
  • TABLE 119. JAPAN SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 120. MALAYSIA SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. MALAYSIA SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 122. MALAYSIA SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 123. MALAYSIA SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 124. MALAYSIA SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2030 (USD MILLION)
  • TABLE 125. MALAYSIA SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2018-2030 (USD MILLION)
  • TABLE 126. MALAYSIA SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 127. PHILIPPINES SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. PHILIPPINES SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 129. PHILIPPINES SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 130. PHILIPPINES SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 131. PHILIPPINES SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2030 (USD MILLION)
  • TABLE 132. PHILIPPINES SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2018-2030 (USD MILLION)
  • TABLE 133. PHILIPPINES SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 134. SINGAPORE SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. SINGAPORE SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 136. SINGAPORE SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 137. SINGAPORE SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 138. SINGAPORE SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2030 (USD MILLION)
  • TABLE 139. SINGAPORE SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2018-2030 (USD MILLION)
  • TABLE 140. SINGAPORE SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 141. SOUTH KOREA SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. SOUTH KOREA SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 143. SOUTH KOREA SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 144. SOUTH KOREA SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 145. SOUTH KOREA SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2030 (USD MILLION)
  • TABLE 146. SOUTH KOREA SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2018-2030 (USD MILLION)
  • TABLE 147. SOUTH KOREA SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 148. TAIWAN SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. TAIWAN SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 150. TAIWAN SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 151. TAIWAN SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 152. TAIWAN SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2030 (USD MILLION)
  • TABLE 153. TAIWAN SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2018-2030 (USD MILLION)
  • TABLE 154. TAIWAN SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 155. THAILAND SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. THAILAND SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 157. THAILAND SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 158. THAILAND SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 159. THAILAND SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2030 (USD MILLION)
  • TABLE 160. THAILAND SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2018-2030 (USD MILLION)
  • TABLE 161. THAILAND SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 162. VIETNAM SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 163. VIETNAM SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 164. VIETNAM SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 165. VIETNAM SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 166. VIETNAM SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2030 (USD MILLION)
  • TABLE 167. VIETNAM SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2018-2030 (USD MILLION)
  • TABLE 168. VIETNAM SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 169. EUROPE, MIDDLE EAST & AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. EUROPE, MIDDLE EAST & AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 171. EUROPE, MIDDLE EAST & AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 172. EUROPE, MIDDLE EAST & AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 173. EUROPE, MIDDLE EAST & AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2030 (USD MILLION)
  • TABLE 174. EUROPE, MIDDLE EAST & AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2018-2030 (USD MILLION)
  • TABLE 175. EUROPE, MIDDLE EAST & AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 176. EUROPE, MIDDLE EAST & AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 177. DENMARK SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. DENMARK SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 179. DENMARK SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 180. DENMARK SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 181. DENMARK SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2030 (USD MILLION)
  • TABLE 182. DENMARK SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2018-2030 (USD MILLION)
  • TABLE 183. DENMARK SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 184. EGYPT SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 185. EGYPT SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 186. EGYPT SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 187. EGYPT SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 188. EGYPT SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2030 (USD MILLION)
  • TABLE 189. EGYPT SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2018-2030 (USD MILLION)
  • TABLE 190. EGYPT SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 191. FINLAND SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 192. FINLAND SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 193. FINLAND SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 194. FINLAND SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 195. FINLAND SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2030 (USD MILLION)
  • TABLE 196. FINLAND SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2018-2030 (USD MILLION)
  • TABLE 197. FINLAND SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 198. FRANCE SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 199. FRANCE SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 200. FRANCE SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 201. FRANCE SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 202. FRANCE SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2030 (USD MILLION)
  • TABLE 203. FRANCE SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2018-2030 (USD MILLION)
  • TABLE 204. FRANCE SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 205. GERMANY SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 206. GERMANY SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 207. GERMANY SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 208. GERMANY SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 209. GERMANY SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2030 (USD MILLION)
  • TABLE 210. GERMANY SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2018-2030 (USD MILLION)
  • TABLE 211. GERMANY SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 212. ISRAEL SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 213. ISRAEL SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 214. ISRAEL SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 215. ISRAEL SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 216. ISRAEL SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2030 (USD MILLION)
  • TABLE 217. ISRAEL SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2018-2030 (USD MILLION)
  • TABLE 218. ISRAEL SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 219. ITALY SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 220. ITALY SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 221. ITALY SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 222. ITALY SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 223. ITALY SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2030 (USD MILLION)
  • TABLE 224. ITALY SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2018-2030 (USD MILLION)
  • TABLE 225. ITALY SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 226. NETHERLANDS SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 227. NETHERLANDS SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 228. NETHERLANDS SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 229. NETHERLANDS SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 230. NETHERLANDS SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2030 (USD MILLION)
  • TABLE 231. NETHERLANDS SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2018-2030 (USD MILLION)
  • TABLE 232. NETHERLANDS SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 233. NIGERIA SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 234. NIGERIA SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 235. NIGERIA SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 236. NIGERIA SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 237. NIGERIA SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2030 (USD MILLION)
  • TABLE 238. NIGERIA SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2018-2030 (USD MILLION)
  • TABLE 239. NIGERIA SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 240. NORWAY SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 241. NORWAY SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 242. NORWAY SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 243. NORWAY SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 244. NORWAY SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2030 (USD MILLION)
  • TABLE 245. NORWAY SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2018-2030 (USD MILLION)
  • TABLE 246. NORWAY SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 247. POLAND SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 248. POLAND SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 249. POLAND SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 250. POLAND SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 251. POLAND SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2030 (USD MILLION)
  • TABLE 252. POLAND SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2018-2030 (USD MILLION)
  • TABLE 253. POLAND SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 254. QATAR SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 255. QATAR SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 256. QATAR SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 257. QATAR SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 258. QATAR SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2030 (USD MILLION)
  • TABLE 259. QATAR SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2018-2030 (USD MILLION)
  • TABLE 260. QATAR SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 261. RUSSIA SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 262. RUSSIA SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 263. RUSSIA SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 264. RUSSIA SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 265. RUSSIA SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2030 (USD MILLION)
  • TABLE 266. RUSSIA SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2018-2030 (USD MILLION)
  • TABLE 267. RUSSIA SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 268. SAUDI ARABIA SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 269. SAUDI ARABIA SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 270. SAUDI ARABIA SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 271. SAUDI ARABIA SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 272. SAUDI ARABIA SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2030 (USD MILLION)
  • TABLE 273. SAUDI ARABIA SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2018-2030 (USD MILLION)
  • TABLE 274. SAUDI ARABIA SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 275. SOUTH AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 276. SOUTH AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 277. SOUTH AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 278. SOUTH AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 279. SOUTH AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2030 (USD MILLION)
  • TABLE 280. SOUTH AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2018-2030 (USD MILLION)
  • TABLE 281. SOUTH AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 282. SPAIN SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 283. SPAIN SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 284. SPAIN SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 285. SPAIN SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 286. SPAIN SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2030 (USD MILLION)
  • TABLE 287. SPAIN SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2018-2030 (USD MILLION)
  • TABLE 288. SPAIN SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 289. SWEDEN SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 290. SWEDEN SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 291. SWEDEN SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 292. SWEDEN SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 293. SWEDEN SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2030 (USD MILLION)
  • TABLE 294. SWEDEN SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2018-2030 (USD MILLION)
  • TABLE 295. SWEDEN SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 296. SWITZERLAND SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 297. SWITZERLAND SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 298. SWITZERLAND SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 299. SWITZERLAND SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 300. SWITZERLAND SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2030 (USD MILLION)
  • TABLE 301. SWITZERLAND SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2018-2030 (USD MILLION)
  • TABLE 302. SWITZERLAND SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 303. TURKEY SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 304. TURKEY SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 305. TURKEY SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 306. TURKEY SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 307. TURKEY SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2030 (USD MILLION)
  • TABLE 308. TURKEY SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2018-2030 (USD MILLION)
  • TABLE 309. TURKEY SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 310. UNITED ARAB EMIRATES SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 311. UNITED ARAB EMIRATES SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 312. UNITED ARAB EMIRATES SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 313. UNITED ARAB EMIRATES SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 314. UNITED ARAB EMIRATES SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2030 (USD MILLION)
  • TABLE 315. UNITED ARAB EMIRATES SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2018-2030 (USD MILLION)
  • TABLE 316. UNITED ARAB EMIRATES SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 317. UNITED KINGDOM SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 318. UNITED KINGDOM SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 319. UNITED KINGDOM SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 320. UNITED KINGDOM SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 321. UNITED KINGDOM SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2030 (USD MILLION)
  • TABLE 322. UNITED KINGDOM SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2018-2030 (USD MILLION)
  • TABLE 323. UNITED KINGDOM SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 324. SEPSIS DIAGNOSTIC MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 325. SEPSIS DIAGNOSTIC MARKET, FPNV POSITIONING MATRIX, 2023